Juan J. Uranga-Rodriguez

Sevilla, AN, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications

DECREASE study: A European pool-analysis of patients with significant reductions in concomitant antiseizure medications in cenobamate Early Access Programs.

DECREASE study: A European pool-analysis of patients with significant reductions in concomitant antiseizure medications in cenobamate Early Access Programs.

Journal: Epilepsia open
Published: June 08, 2026

Effectiveness and tolerability of fenfluramine in pediatric and adult patients with developmental and epileptic encephalopathies: A multicenter, retrospective, real-world clinical-practice study.

Effectiveness and tolerability of fenfluramine in pediatric and adult patients with developmental and epileptic encephalopathies: A multicenter, retrospective, real-world clinical-practice study.

Journal: Epilepsia
Published: March 11, 2026

Freedon study: Real-life outcomes of cenobamate in different lines of treatment.

Freedon study: Real-life outcomes of cenobamate in different lines of treatment.

Journal: Epilepsia
Published: November 04, 2025

Impact of long-term treatment with cenobamate on concomitant usage of antiseizure medications: A real-world retrospective study in Spain.

Impact of long-term treatment with cenobamate on concomitant usage of antiseizure medications: A real-world retrospective study in Spain.

Journal: Epilepsia
Published: July 07, 2025

Spanish translation, adaptation, and validation of the Epilepsy Surgery Satisfaction Questionnaire-19.

Spanish translation, adaptation, and validation of the Epilepsy Surgery Satisfaction Questionnaire-19.

Journal: Epilepsia
Published: July 02, 2025

Delphi consensus on referral criteria for pediatric patients with suspected Dravet syndrome.

Delphi consensus on referral criteria for pediatric patients with suspected Dravet syndrome.

Journal: Epilepsy & behavior : E&B
Published: December 30, 2024

Advances and guidance in the treatment of drug-resistant epilepsy: a review by the Andalusian Epilepsy Society of the new drugs cenobamate, fenfluramine and cannabidiol

Advances and guidance in the treatment of drug-resistant epilepsy: a review by the Andalusian Epilepsy Society of the new drugs cenobamate, fenfluramine and cannabidiol

Journal: Revista de neurologia
Published: September 13, 2024

Treatment administration during a seizure in home-settings: Time to treat (TT).

Treatment administration during a seizure in home-settings: Time to treat (TT).

Journal: Medicina clinica
Published: August 05, 2024

BRIVA-ONE study: 12-month outcomes of brivaracetam monotherapy in clinical practice.

BRIVA-ONE study: 12-month outcomes of brivaracetam monotherapy in clinical practice.

Journal: Epilepsia open
Published: June 28, 2024

Spanish consensus on the management of concomitant antiseizure medications when using cenobamate in adults with drug-resistant focal seizures.

Spanish consensus on the management of concomitant antiseizure medications when using cenobamate in adults with drug-resistant focal seizures.

Journal: Epilepsia open
Published: January 22, 2024

Treatment simplification to optimize cenobamate effectiveness and tolerability: A real-world retrospective study in Spain.

Treatment simplification to optimize cenobamate effectiveness and tolerability: A real-world retrospective study in Spain.

Journal: Epilepsia open
Published: September 22, 2023

Value contribution of cenobamate for the treatment of Focal-Onset Seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through reflective Multi-Criteria Decision Analysis (MCDA).

Value contribution of cenobamate for the treatment of Focal-Onset Seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through reflective Multi-Criteria Decision Analysis (MCDA).

Journal: Epilepsy & behavior : E&B
Published: April 27, 2023
Showing 1-12 of 33

Last Updated: 09/26/2026